Another article that mentions Recce. I don't have access to the whole thing unfortunately.
It is for BioWorld Asia. Great to see Recce turning heads in the Asia market. So much scope there. Deep pockets and if they were to do testing I assume they might have less stringent standards than Australia and could get some product to market faster.
Anyone think otherwise? I could see an argument that Recce might not let their product be tested over there due to IP issues etc
RCE Price at posting:
$1.35 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)